Alkermes News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

03.04.18	RSLS Deflated, ALKS Depressed, ALNY On Watch (RTTNews)
02.04.18	Panikverkäufe an der Wall Street (Dow Jones)
02.04.18	MÄRKTE USA/Handelsstreit und Tech-Debakel drücken Wall Street (Dow Jones)
02.04.18	MÄRKTE USA/Handelsstreit belastet Wall Street (Dow Jones)
02.04.18	MÄRKTE USA/Handelsstreit dürfte Wall Street belasten (Dow Jones)
02.04.18	Alkermes Receives Refusal Letter From FDA On NDA Filing For ALKS 5461 (RTTNews)
02.04.18	Alkermes Receives Refusal to File Letter From FDA for ALKS 5461 (PR Newswire)
02.04.18	Alkermes Receives Refusal to File Letter From FDA for ALKS 5461 (PR Newswire)
05.03.18	Alkermes' Corporate Presentation to be Webcast at Upcoming Healthcare Conferences (PR Newswire)
05.03.18	Alkermes' Corporate Presentation to be Webcast at Upcoming Healthcare Conferences (PR Newswire)
01.03.18	Alkermes Appoints James Robinson As President And COO - Quick Facts (RTTNews)
01.03.18	Alkermes Appoints James Robinson as President and Chief Operating Officer (PR Newswire)
01.03.18	Alkermes Appoints James Robinson as President and Chief Operating Officer (PR Newswire)
23.02.18	ADXS Falls On Stock Offering, OMER Down 36% In 5 Days, Analyst Downgrades ALKS (RTTNews)
14.02.18	Alkermes Appoints Shane Cooke to Board of Directors (PR Newswire)
14.02.18	Alkermes Appoints Shane Cooke to Board of Directors (PR Newswire)
14.02.18	Alkermes plc Bottom Line Rises In Q4 (RTTNews)
14.02.18	Alkermes plc Reports Financial Results for the Year Ended Dec. 31, 2017 and Provides Financial Expectations for 2018 (PR Newswire)
14.02.18	Alkermes plc Reports Financial Results for the Year Ended Dec. 31, 2017 and Provides Financial Expectations for 2018 (PR Newswire)
07.02.18	Alkermes To Host Conference Call To Discuss Fourth Quarter And Year-End 2017 Financial Results (PR Newswire)
07.02.18	Alkermes To Host Conference Call To Discuss Fourth Quarter And Year-End 2017 Financial Results (PR Newswire)
31.01.18	Alkermes Submits New Drug Application To U.S. FDA For ALKS 5461 For The Adjunctive Treatment Of Major Depressive Disorder (PR Newswire)
31.01.18	Alkermes Submits New Drug Application To U.S. FDA For ALKS 5461 For The Adjunctive Treatment Of Major Depressive Disorder (PR Newswire)
16.12.17	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alkermes plc of Class Action Lawsuit and Upcoming Deadline - ALKS (PR Newswire)
12.12.17	Scott+Scott, Attorneys at Law, LLP Alerts Investors to the Filing of Securities Class Action Against Alkermes plc (ALKS) (PR Newswire)
02.12.17	ALKERMES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Alkermes plc To Contact The Firm (PR Newswire)
28.11.17	BIIB & ALKS Team Up For MS Drug, REGN's Eylea Combo Fails Again, AEZS Rises (RTTNews)
27.11.17	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Alkermes plc (ALKS) & Lead Plaintiff Deadline - January 22, 2018 (PR Newswire)
27.11.17	Biogen In Deal With Alkermes To Develop, Commercialize ALKS 8700 For MS (RTTNews)
17.11.17	FDA Nod For Label Expansion Of Sutent, Egalet Flies, Double Blessing For Roche (RTTNews)
16.11.17	Alkermes Says FDA Accepts NDA Filing On ARISTADA (RTTNews)
11.11.17	ACT NOW: Monteverde & Associates PC Announces an Investigation of Alkermes plc. - ALKS (PR Newswire)
07.11.17	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alkermes plc (ALKS) (PR Newswire)
07.11.17	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alkermes plc - ALKS (PR Newswire)
07.11.17	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alkermes plc - ALKS (PR Newswire)
07.11.17	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alkermes plc - ALKS (PR Newswire)
27.10.17	NEOS Soars On Buyout Bid, INSY Plunges On Founder's Arrest, CELG Bleeds (RTTNews)
26.10.17	Alkermes Updates 2017 Financial Expectations - Quick Facts (RTTNews)
26.10.17	EARNINGS SUMMARY: Details of Alkermes plc Q3 Earnings Report (RTTNews)
22.08.17	FDA Approves IRWD's Gout Drug, It's A Thumbs Up For ALXN In EU, CRME Crushed (RTTNews)
21.08.17	Alkermes Initiates NDA Submission Of ALKS 5461 For Major Depressive Disorder (RTTNews)
27.07.17	EARNINGS SUMMARY: Details of Alkermes plc Q2 Earnings Report (RTTNews)
14.07.17	Technical Reports on Drug Delivery Equities -- PetMed Express, Adamis Pharma, Delcath Systems, and Alkermes (PR Newswire)
30.06.17	CARA In Pain, ALKS Enlightened, FDA Expands Approved Use Of AMGN's Vectibix (RTTNews)
08.06.17	Alkermes Begins Supportive Study In ALKS 3831 ENLIGHTEN Development Program (RTTNews)
07.06.17	FDA Panel To Review PTCT's Translarna, CTIC Plunges On Offering, NNVC Abuzz (RTTNews)
06.06.17	Alkermes: FDA Approves Two-Month ARISTADA To Treat Schizophrenia - Quick Facts (RTTNews)
30.05.17	Research Reports Coverage on Drug Delivery Stocks -- Valeant Pharma, Delcath Systems, Alkermes, and Adamis Pharma (PR Newswire)
25.05.17	Biotech Stocks Facing FDA Decision In June (RTTNews)
27.04.17	EARNINGS SUMMARY: Details of Alkermes plc Q1 Earnings Report (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Alkermes PLC

Aktien Top/Flop

Meistgelesene Nachrichten